Uğur Şahin, BioNTech CEO (Bernd von Jutrczenka/dpa via AP Images)
August 23, 2022 10:31 AM EDT
Coronavirus

Covid-19 roundup: Pfiz­er/BioN­Tech add on vac­cine da­ta for young chil­dren; Mex­i­co says it's miss­ing vac­cine dos­es from UN

Lei Lei Wu

News Reporter

A three-dose vac­cine se­ries was 73.2% ef­fec­tive in pre­vent­ing Covid-19 for chil­dren be­tween 6 months and 4 years old, Pfiz­er and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

Ma­jor PBM re­forms fea­ture in Con­gress' year-end spend­ing bill

What Trump’s FTC picks mean for bio­phar­ma deal­mak­ing and PBMs

Up­dat­ed: Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

A service from the Financial Times